XYOSTED

NDC 54436-250 · Antares Pharma, Inc.

Generic nametestosterone enanthate

Dosage formINJECTION

RouteSUBCUTANEOUS

Active ingredient(s)TESTOSTERONE ENANTHATE

Strength50 mg/.5mL

Pharmacologic classAndrogen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]

DEA scheduleCIII

Marketing categoryNDA

Packages

54436-250-01 — 1 SYRINGE in 1 CARTON (54436-250-01) / .5 mL in 1 SYRINGE (54436-250-03)

54436-250-04 — 4 SYRINGE in 1 CARTON (54436-250-04) / .5 mL in 1 SYRINGE (54436-250-02)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9750 — TESTOSTERONE ENANTHATE, 54436-200 — testosterone enanthate, 54436-275 — testosterone enanthate, 55150-336 — TESTOSTERONE ENANTHATE

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources